课题基金 / 基金详情

Development and Validation of Clinical Prediction Rules for Bleeding for Patients on Anticoagulation Therapy for Venous Thromboembolism

Development and Validation of Clinical Prediction Rules for Bleeding for Patients on Anticoagulation Therapy for Venous Thromboembolism
静脉血栓栓塞抗凝治疗患者出血临床预测规则的制定和验证
批准号：
279357
负责人：
Wells Philip S
金额：
$36.5万
依托单位：
Ottawa Hospital General Campus (Ottawa Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-03-01 至 2016-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=279357&lang=en
关键词：
Anticoagulation Bleeding Blood Coagulation Factors Epidemiology Venous Thrombosis

项目摘要

项目成果

Wells Philip S的其他基金

相似基金

相关文献

中文摘要
翻译
血液稀释剂可以防止已经形成深静脉血栓或已经转移到肺部的血栓的患者形成新的血栓。然而，与使用它们相关的大出血是一个问题，因为它将导致12%的病例死亡。一些p
英文摘要
Blood thinners prevent the formation of new clots in patients who have developed deep vein blood clots or clots that have traveled to the lungs. However, major bleeding associated with their use is a problem, as it will cause death in 12% of cases. Some p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Oral Anticoagulants for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients: A Randomized Placebo-Controlled, Double-Blind Clinical Trial
海外基金